Monitoring and antibacterial treatment for postoperative bacterial overgrowth in Crohn's disease

被引:16
|
作者
Funayama, Y
Sasaki, I
Naito, H
Fukushima, K
Shibata, C
Masuko, T
Takahashi, K
Ogawa, H
Sato, S
Ueno, T
Noguchi, M
Hiwatashi, N
Matsuno, S
机构
[1] Tohoku Univ, Sch Med, Dept Surg 1, Aoba Ku, Sendai, Miyagi 9808574, Japan
[2] Tohoku Univ, Sch Med, Dept Internal Med 3, Aoba Ku, Sendai, Miyagi 9808574, Japan
关键词
Crohn's disease; bacterial overgrowth syndrome; hydrogen breath test; antibiotics;
D O I
10.1007/BF02236706
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
PURPOSE: Bacterial overgrowth sometimes complicates the clinical course of Crohn's disease and may lead to inappropriate treatment. To clarify the effect of antibiotic therapy, we monitored the hydrogen concentration in expiratory breath after fasting. METHODS: We evaluated 18 patients (15 males; median age, 32.7; range, 22.3-60 years) for postoperative bacterial overgrowth symptoms and for intestinal dilation by plain abdominal x-ray. Five patients had ileitis and 13 patients had ileocolitis. Various intestinal resections were performed in all, and strictureplasties were done at the same time in 13 patients. The median postoperative period was 10.2 (range, 1.2-102) months. Nine patients, who had symptoms such as bloating, nausea, vomiting, or pain, were classified as the symptomatic group, whereas nine other patients, who had no symptoms, were classified as the symptom-free group. Sixteen patients who bad undergone intestinal resections for noninflammatory bowel disease served as the control group. After overnight fasting, hydrogen concentration in end-expiratory breath was measured with gas chromatography. At the same time clinical examinations of white blood cell count, hemoglobin, total protein, serum albumin, iron, sialic acid, and C-reactive protein in the peripheral blood were performed. To assess the effect of antibacterial treatment, changes in symptoms were assessed in eight patients who received antibacterial treatment. Hydrogen concentration was measured repeatedly before and after treatment in six patients. RESULTS: The symptomatic group had an expiratory hydrogen concentration level significantly higher (median, 40; range, 20-139 ppm) than the control group (median, 3; range, 1-6 ppm) and the symptom-free group (median, 4; range, 1-10 ppm). After the antibiotic treatment the symptoms were improved in all of the patients, and the hydrogen concentration level was significantly reduced (median, 4.5; range, 2-13 ppm). CONCLUSIONS: Antibacterial treatment was useful in the postoperative patients whose assessments were complicated by bacterial overgrowth. Using a hydrogen breath test, bacterial overgrowth was effectively monitored and managed, effecting a change in clinical symptoms.
引用
收藏
页码:1072 / 1077
页数:6
相关论文
共 50 条
  • [41] GLUCOSE BREATH TEST AND CROHN'S DISEASE: DIAGNOSIS OF SMALL INTESTINAL BACTERIAL OVERGROWTH AND EVALUATION OF THERAPEUTIC RESPONSE
    Greco, A.
    Caviglia, G. P.
    Ribaldone, D. G.
    Brignolo, P.
    Reggiani, S.
    Sguazzini, C.
    Smedile, A.
    Pellicano, R.
    Resegotti, A.
    Astegiano, M.
    DIGESTIVE AND LIVER DISEASE, 2015, 47 : E177 - E177
  • [42] Glucose breath test and Crohn's disease: Diagnosis of small intestinal bacterial overgrowth and evaluation of therapeutic response
    Greco, Anna
    Caviglia, Gian Paolo
    Brignolo, Paola
    Ribaldone, Davide Giuseppe
    Reggiani, Stefania
    Sguazzini, Carlo
    Smedile, Antonina
    Pellicano, Rinaldo
    Resegotti, Andrea
    Astegiano, Marco
    Bresso, Francesca
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2015, 50 (11) : 1376 - 1381
  • [43] Small intestinal bacterial overgrowth in Alzheimer's disease
    Kowalski, Karol
    Mulak, Agata
    JOURNAL OF NEURAL TRANSMISSION, 2022, 129 (01) : 75 - 83
  • [44] Small intestinal bacterial overgrowth in Parkinson's disease
    Tan, Ai Huey
    Mahadeva, Sanjiv
    Thalha, Abdul Malik
    Gibson, Peter R.
    Kiew, Chiun Khang
    Yeat, Chia Ming
    Ng, Sheang Wen
    Ang, Sheau Phing
    Chow, Siew Kian
    Tan, Chong Tin
    Yong, Hoi Sen
    Marras, Connie
    Fox, Susan H.
    Lim, Shen-Yang
    PARKINSONISM & RELATED DISORDERS, 2014, 20 (05) : 535 - 540
  • [45] Small intestinal bacterial overgrowth in Alzheimer’s disease
    Karol Kowalski
    Agata Mulak
    Journal of Neural Transmission, 2022, 129 : 75 - 83
  • [46] Risk of postoperative recurrence and postoperative management of Crohn's disease
    Spinelli, Antonino
    Sacchi, Matteo
    Fiorino, Gionata
    Danese, Silvio
    Montorsi, Marco
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (27) : 3213 - 3219
  • [47] Vedolizumab is effective in the prevention and treatment of postoperative recurrence in patients with Crohn's disease
    Kadleckova, B.
    Podmanicky, D.
    Lipovska, A.
    Zelinkova, Z.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I470 - I470
  • [48] Prevention and treatment of postoperative Crohn's disease recurrence: An update for a new decade
    Schwartz M.
    Regueiro M.
    Current Gastroenterology Reports, 2011, 13 (1) : 95 - 100
  • [49] Vedolizumab may be an effective option for the treatment of postoperative recurrence of Crohn's disease
    Macaluso, Fabio Salvatore
    Cappello, Maria
    Crispino, Federica
    Grova, Mauro
    Privitera, Antonino Carlo
    Piccillo, Giovita
    Magnano, Antonio
    Ferracane, Concetta
    Belluardo, Nunzio
    Giangreco, Emiliano
    Fries, Walter
    Viola, Anna
    Di Mitri, Roberto
    Mocciaro, Filippo
    Camilleri, Salvatore
    Garufi, Serena
    Renna, Sara
    Casa, Angelo
    Maida, Marcello
    Orlando, Ambrogio
    Dis, Sicilian Network Inflamatory Bowel
    DIGESTIVE AND LIVER DISEASE, 2022, 54 (05) : 629 - 634
  • [50] Risk of postoperative recurrence and postoperative management of Crohn's disease
    Antonino Spinelli
    Matteo Sacchi
    Gionata Fiorino
    Silvio Danese
    Marco Montorsi
    World Journal of Gastroenterology, 2011, 17 (27) : 3213 - 3219